Description:

University and Industry Perspectives on Repurposing Drugs: Successes, Pitfalls and Patent Opportunities PART TWO

Join INVO for a follow-up presentation about the opportunities and challenges related to the commercialization of repurposed drugs.

Mike Moore, Director of Licensing and Life Sciences

John Haugen, Associate General Counsel

Drug repurposing is the application of already tested or approved drugs and compounds for new indications. This area saw a spike in popularity in the 1990's and 2000s with the success of drugs such as Viagra, Thalidomide, and Botox and is currently reemerging as a big opportunity highlighted by renewed interest from the NIH National Center for Advancing Translation Sciences (NCATS), patient foundations, industry and investors. In the previous session on Feb 28, 2018, an overview of the patent, regulatory and other commercial considerations were presented, alongside recent University/Industry success stories in this field.

This seminar will dive deeper into patents and patentability of repurposed drugs. The speakers will also share university success stories. All are welcome to attend irrespective of attending the first session.